|
|
Blood, 15 January 2005, Vol. 105, No. 2, pp. 838-846.
Prepublished online as a Blood First Edition Paper on July 6, 2004; DOI 10.1182/blood-2004-03-1016.
 Previous Article | Table of Contents | Next Article 
RED CELLS
Two-phase culture in Diamond Blackfan anemia: localization of erythroid defect
Yaw Ohene-Abuakwa,
Karen A. Orfali,
Carine Marius, and
Sarah E. Ball
From the Department of Cellular and Molecular Medicine (Haematology), St George's Hospital Medical School, London, United Kingdom.
The erythroid defect in Diamond Blackfan anemia (DBA) is known to be intrinsic to the stem cell, but its molecular pathophysiology remains obscure. Using a 2-phase liquid erythroid culture system, we have demonstrated a consistent defect in DBA, regardless of clinical severity, including 3 first-degree relatives with normal hemoglobin levels but increased erythrocyte adenosine deaminase activity. DBA cultures were indistinguishable from controls until the end of erythropoietin (Epo)–free phase 1, but failed to demonstrate the normal synchronized wave of erythroid expansion and terminal differentiation on exposure to Epo. Dexamethasone increased Epo sensitivity of erythroid progenitor cells, and enhanced erythroid expansion in phase 2 in both normal and DBA cultures. In DBA cultures treated with dexamethasone, Epo sensitivity was comparable to normal, but erythroid expansion remained subnormal. In clonogenic phase 2 cultures, the number of colonies did not significantly differ between normal cultures and DBA, in the presence or absence of dexamethasone, and at both low and high Epo concentrations. However, colonies were markedly smaller in DBA under all conditions. This suggests that the Epo-triggered onset of terminal maturation is intact in DBA, and the defect lies down-stream of the Epo receptor, influencing survival and/or proliferation of erythroid progenitors.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
-
Diamond-Blackfan anemia: a "cultural" diagnosis
- Blanche P. Alter
Blood 2005 105: 435-436.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
K. Miyake, T. Utsugisawa, J. Flygare, T. Kiefer, I. Hamaguchi, J. Richter, and S. Karlsson
Ribosomal Protein S19 Deficiency Leads to Reduced Proliferation and Increased Apoptosis but Does Not Affect Terminal Erythroid Differentiation in a Cell Line Model of Diamond-Blackfan Anemia
Stem Cells,
February 1, 2008;
26(2):
323 - 329.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Flygare and S. Karlsson
Diamond-Blackfan anemia: erythropoiesis lost in translation
Blood,
April 15, 2007;
109(8):
3152 - 3154.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. T. Gazda, A. T. Kho, D. Sanoudou, J. M. Zaucha, I. S. Kohane, C. A. Sieff, and A. H. Beggs
Defective Ribosomal Protein Gene Expression Alters Transcription, Translation, Apoptosis, and Oncogenic Pathways in Diamond-Blackfan Anemia
Stem Cells,
September 1, 2006;
24(9):
2034 - 2044.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Coulombel
RPS19: pleads guilty in DBA case?
Blood,
June 15, 2005;
105(12):
4549 - 4550.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. L. Ebert, M. M. Lee, J. L. Pretz, A. Subramanian, R. Mak, T. R. Golub, and C. A. Sieff
An RNA interference model of RPS19 deficiency in Diamond-Blackfan anemia recapitulates defective hematopoiesis and rescue by dexamethasone: identification of dexamethasone-responsive genes by microarray
Blood,
June 15, 2005;
105(12):
4620 - 4626.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Flygare, T. Kiefer, K. Miyake, T. Utsugisawa, I. Hamaguchi, L. Da Costa, J. Richter, E. J. Davey, H. Matsson, N. Dahl, et al.
Deficiency of ribosomal protein S19 in CD34+ cells generated by siRNA blocks erythroid development and mimics defects seen in Diamond-Blackfan anemia
Blood,
June 15, 2005;
105(12):
4627 - 4634.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
